EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Rapid Annotation Strategy for in Vivo Phase II Metabolites of Anabolic–Androgenic Steroids Using Liquid Chromatography–Ion Mobility–Mass Spectrometry

David C Koomen iD, Katrina L Leaptrot iD, Jody C May iD, Bailey S Rose iD, Kyle E Lira iD, Julia A Raziel, Andrew D Pumford, Gustavo de A Cavalcanti iD, Monica C Padilha, Henrique M G Pereira, John A McLean iD

Journal of the American Society for Mass Spectrometry · 2025

DOI: 10.1021/jasms.5c00129 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society for Mass Spectrometry, 2025. Verfasst von David C Koomen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Center for Innovative Technology, Vanderbilt University, Nashville, Tennessee 37235, United States. Hauptthemen laut MEDLINE: Data Curation, Metabolic Detoxication, Phase II, Anabolic Androgenic Steroids, Oxymetholone. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, Partnership for Clean Competition.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Doping control laboratories are responsible for the precise measurement of anabolic-androgenic steroids (AASs) and determination of athlete usage. Intact phase II AASs are difficult to analyze due to their low abundance in complex biological matrices and their structural similarities that convolute tandem mass spectrometry interpretation. Discovery efforts of unknown phase II metabolites of new-to-the-field steroids have been challenging due to these deficiencies in current analytical techniques. Several methods for determining unknown conjugated AAS compounds have been developed that include deuterium tagging, fractionation, derivatization, and utilization of synthesized standards. Ion mobility (IM), a rapid gas-phase separation, allows for improved molecular differentiation and provides additional information for analyzing intact phase II AASs without sacrificing throughput. Here, candidate metabolites were putatively identified for oxymetholone (OXM) and methyl-1-testosterone (M1T) utilizing liquid chromatography-ion mobility-mass spectrometry (LC-IM-MS) and two independent data analysis strategies: a fully untargeted approach using mass defect analysis and collision cross section (CCS) filtering and a pseudotargeted approach using the biologically anticipated isotopic envelope in conjunction with CCS filtering, temporal profiling, and tandem mass spectrometry confirmation. A proof-of-concept time-course study was conducted using the urine from healthy male individuals after steroid administration. The fully untargeted approach reduced the number of original features by >85% while the pseudotargeted approach reduced original features by >99%, yielding 11 possible novel phase II AAS candidates for OXM and 23 for M1T.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Data CurationMetabolic Detoxication, Phase IIAnabolic Androgenic SteroidsOxymetholoneMethyltestosteroneIon Mobility SpectrometryLiquid Chromatography-Mass SpectrometryDoping in SportsHumansMaleProof of Concept Study

Stichwörter der Autor:innen

CCS regression modelLC-IM-MSmass−mobility correlationnontargeted discovery workflowphase II AASuntargeted metabolomics

Substanzen

Anabolic Androgenic SteroidsOxymetholoneMethyltestosterone

Autor:innen und Institutionen

  • Department of Chemistry, Center for Innovative Technology, Vanderbilt University, Nashville, Tennessee 37235, United States.
  • Brazilian Doping Control Laboratory (LBCD), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, RJ 21941, Brazil.

ORCID-Profile: David C Koomen, Katrina L Leaptrot, Jody C May, Bailey S Rose, Kyle E Lira, Gustavo de A Cavalcanti, John A McLean

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Partnership for Clean Competition

Zitieren

APA

Koomen, D. C., Leaptrot, K. L., May, J. C., Rose, B. S., Lira, K. E., Raziel, J. A., Pumford, A. D., de A Cavalcanti, G., Padilha, M. C., Pereira, H. M. G., & McLean, J. A. (2025). Rapid Annotation Strategy for in Vivo Phase II Metabolites of Anabolic–Androgenic Steroids Using Liquid Chromatography–Ion Mobility–Mass Spectrometry. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.5c00129

Vancouver

Koomen DC, Leaptrot KL, May JC, Rose BS, Lira KE, Raziel JA, et al. Rapid Annotation Strategy for in Vivo Phase II Metabolites of Anabolic–Androgenic Steroids Using Liquid Chromatography–Ion Mobility–Mass Spectrometry. Journal of the American Society for Mass Spectrometry. 2025. doi:10.1021/jasms.5c00129

BibTeX
@article{Koomen2025,
  author = {Koomen, David C and Leaptrot, Katrina L and May, Jody C and Rose, Bailey S and Lira, Kyle E and Raziel, Julia A and Pumford, Andrew D and de A Cavalcanti, Gustavo and Padilha, Monica C and Pereira, Henrique M G and McLean, John A},
  title = {Rapid Annotation Strategy for in Vivo Phase II Metabolites of Anabolic–Androgenic Steroids Using Liquid Chromatography–Ion Mobility–Mass Spectrometry},
  journal = {Journal of the American Society for Mass Spectrometry},
  year = {2025},
  doi = {10.1021/jasms.5c00129}
}
Kostenlos starten →